Strategies for Enhancing Oligonucleotide Drug Formulation With Patient Adherence in Mind

Time: 1:30 pm
day: Day 1


  • Conducting stability assessments to address potential degradation products and de-risk larger scale production
  • Optimizing process and excipient selection for potential novel formulas to ensure safety
  • Navigating formulations, such as choice of salt and pH, to increase administration options and improve patient adherence